Growing patient preference for noninvasive and minimally invasive surgical treatments

Asia-Pacific market is expected to grow at the highest CAGR

In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusi

[153 Pages Report] The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.

The Global Bone Growth Stimulators Market is expected to reach $ 1.41 billion, at a CAGR of 5.4%

[153 Pages Report] The global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.